OTC · Medical - Instruments & Supplies

CeCors, Inc. (CEOS) Stock

$0.01 -14.08% OTC: CEOS Healthcare

CeCors, Inc. engages in the acquisition and development of healthcare companies focusing on military veterans.

Valuation

MetricValue
Price$0.01
Market Cap$1.91M
P/E Ratio0.67
P/B Ratio1.12
P/S Ratio0.00
EPS (TTM)$0.01
52-Week High$0.01
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE733.40%
ROA85.50%
ROCE-104.59%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio1.77

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$6.0M$0
Operating Profit$0$0$-1.0M$0$-2.0M
Net Profit$0$0$-1.0M$0$3.0M
EPS$0.00$0.00$0.00$0.00$0.01
Op Margin—-1841.9%-190.2%-5.1%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$1.0M$2.0M$4.0M$4.0M
Total Liabilities$1.0M$1.0M$2.0M$5.0M$2.0M
Cash$0$0$0$2.0M$1.0M
Borrowings$1.0M$1.0M$1.0M$1.0M$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$0$2.0M$1.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$2.0M$-2.0M
Free Cash Flow$0$0$0$2.0M$1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-0.70
FCF Yield54.92%
Quick Ratio1.77
Interest Coverage-73.00
Return 1Y5.97%
Return 3Y-81.03%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATTBFAbattis Bioceuticals Corp. $0.00 — -0.01 $14334 0.00%
HADVHealth Advance Inc. $0.00 — 2.00 $32189 0.00%
HDVYHealth Discovery Corporation $0.00 — -0.05 $41171 0.00%
INSDInstadose Pharma Corp. $0.00 — -0.02 $53193 0.00%
ISOLFIsodiol International Inc. $0.00 — 0.00 $4914 0.00%

About CeCors, Inc.

CeCors, Inc. engages in the acquisition and development of healthcare companies focusing on military veterans. It operates through the PsyKey and VETCOMM segments. The PsyKey segment refers to consumer goods. It is related to the sales of coffee products. The VETCOMM segment includes recurring services such as education and resources. The company was founded on April 16, 2002 and is headquartered in Toronto, Canada.

CeCors, Inc. is headquartered in CA.

CeCors, Inc. (CEOS) stock trades at $0.01 with a market capitalization of $1.91M. The stock is valued at a price-to-earnings (P/E) ratio of 0.67, price-to-book of 1.12, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades at its 52-week high.

On profitability, CeCors, Inc. generates a return on equity (ROE) of 733.40% — well above the market average, a sign of a high-quality business, return on capital employed of -104.59%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.cecorsinc.ca

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides